Active Ingredient History

  • Now
Sevoflurane is a general anesthetic that is FDA approved for the induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery. Sevoflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Sevoflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. It also appears to bind the D subunit of ATP synthase and NADH dehydogenase and also binds to the GABA receptor. Common adverse reactions include cardiovascular: bradyarrhythmia, hypotension, gastrointestinal: nausea, vomiting, neurologic: somnolence, psychiatric: agitation, respiratory: cough, interrupted breathing and other: shivering.   NCATS

  • Mol. Mass: 200.0548
  • ALogP: 2.42
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$0.2234 - $66.2800
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)propane | bax 3084 | fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether | fluoromethyl hexafluoroisopropyl ether | mr6s4 | mr-6s4 | sevoflo | sevofluorane | sevofluran | sevoflurane | sevoflurano | sevofluranum | sevofrane | sevorane | sojourn | ultane


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue